End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
61.38 EUR | +0.56% |
|
-3.37% | -10.97% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.97% | 8.43B | - | ||
-4.65% | 1.38B | D | ||
-13.34% | 1.28B | B+ | ||
-5.79% | 1.2B | - | ||
-26.51% | 770M | - | - | |
-.--% | 617M | - | - | |
+3.68% | 466M | - | ||
+2.04% | 433M | - | - | |
-31.93% | 301M | - | - | |
-62.49% | 269M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HSIC Stock
- Ratings Henry Schein, Inc.